Specific caspase-10 inhibitors
US7829721B2 · kind B2 · utility
0Cited by
1References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 2005 |
| Grant date | Nov 9, 2010 |
| Priority date | — |
| Expiry date | Nov 2, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C59/64
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of the general formula (I), and to their use as caspase-10 inhibitors, especially for the treatment of diabetic retinopathy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.